| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/26/2009 | WO2009039175A2 Method for inhibiting bone resorption |
| 03/26/2009 | WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 03/26/2009 | WO2009037813A1 Transdermally absorbable preparation |
| 03/26/2009 | WO2009016451A3 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | WO2009010992A3 A synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds) |
| 03/26/2009 | WO2008145688A3 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 03/26/2009 | WO2008058897A3 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 03/26/2009 | US20090082452 Deuterium-enriched lumiracoxib |
| 03/26/2009 | US20090082450 Deuterium-enriched diclofenac |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082416 Deuterium-enriched bendamustine |
| 03/26/2009 | US20090082411 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 03/26/2009 | US20090082372 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082317 Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3 |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082272 pharmacokinetics; sustained release; cost efficiency; industrial scale |
| 03/26/2009 | US20090082270 myostatin antagonist protein is substantially serum stable for a period of at least 24 hours; treating individuals with muscle wasting conditions and provides further insight into the regulation of myostatin gene expression; muscular disorders |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081313 Biodegradable Magnesium Alloys and Uses Thereof |
| 03/26/2009 | US20090081312 Prevention and treatment of alveolar osteitis |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | US20090081122 Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
| 03/26/2009 | CA2705306A1 Neoepitope detection of disease using protein arrays |
| 03/26/2009 | CA2699417A1 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | CA2695504A1 Compositions and methods for treatment and prevention of osteoarthritis |
| 03/25/2009 | EP2039702A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2039691A1 Process for production of a polymorph of 2-(3-cyano-4- isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2038283A2 Heterobicyclic metalloprotease inhibitors |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1407777B1 Hydrangea(e) for the prevention or treatment of arthritis |
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | CN101394854A Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 03/25/2009 | CN101394851A Gsk-3 inhibitors for the treatment of osteoporosis |
| 03/25/2009 | CN101394841A Fast-acting oral peptide pharmaceutical products |
| 03/25/2009 | CN101392251A Micro RNA capable of inducing stem cell to differentiate toward osteoblasts and use thereof |
| 03/25/2009 | CN101391067A Preparation method of Chinese herbal medicine for treating lumbar vertebra disc protrusion |
| 03/25/2009 | CN101391064A Composition for treating lumbar intervertebral disc protrusion |
| 03/25/2009 | CN101391054A Oral medicine for treating intervertebral disk hyperplasy and protrusion and preparation method thereof |
| 03/25/2009 | CN101391051A Traditional Chinese medicine composition for treating periarthritis humeroscapularis using external application |
| 03/25/2009 | CN101391050A Traditional Chinese medicine capsule for treating cervical-shoulder disease |
| 03/25/2009 | CN101391041A External medicine for treating muscle break |
| 03/25/2009 | CN101391034A Medicine for treating femoral head necrosis |
| 03/25/2009 | CN101391018A Traditional Chinese medicine preparation for effectively treating osteoporosis |
| 03/25/2009 | CN101391005A Health-care medicinal wine capable of relaxing muscles and joints and promoting blood circulation |
| 03/25/2009 | CN101391003A Song family rehabilitation plaster for treating protrusion of intervertebral disc |
| 03/25/2009 | CN101390998A External medicine for treating osteomyelitis |
| 03/25/2009 | CN101390988A Medicine for treating hyperosteogeny |
| 03/25/2009 | CN101390981A Bone fracture traditional Chinese medicine |
| 03/25/2009 | CN101390969A Medicine capable of reducing uric acid content in blood |
| 03/25/2009 | CN101390967A Medicine composition for treating osteoporosis |
| 03/25/2009 | CN101390964A Cataplasm of traditional Chinese medicine for treating hyperosteogeny |
| 03/25/2009 | CN101390960A Medicine composition for treating qi-deficiency kidney-deficiency blood stasis type osteoporosis and preparation method thereof |
| 03/25/2009 | CN101390957A Ancestral traditional Chinese medicine composition for treating injuries from falls |
| 03/25/2009 | CN101390955A External wine for treating foot calcaneus spur |
| 03/25/2009 | CN101390954A External traditional Chinese medicine wine for treating scapulohumeral periarthritis |
| 03/25/2009 | CN101390942A Traditional Chinese medicine pills for treating bone-pain arthralgia |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471512C Medicinal wine for treating rheumatism and rheumatoid disease and its prepn. method |
| 03/25/2009 | CN100471507C Traditional Chinese medicine prepn. for treating osteoporosis |
| 03/25/2009 | CN100471500C Medicinal composition contg. glucoside of pueravia flower and its application |
| 03/25/2009 | CN100471489C Soft capsule containing Lamiophlomis rotata Kudo. root extract |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507715 Administering parathyroid hormone and bone resorption inhibitor; bone disorders |
| 03/24/2009 | US7507712 NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer |
| 03/24/2009 | US7507563 culturing propionibacterium under anaerobic conditions, in medium containing a carbon source such as lactose, to form 1,4-dihydroxynaphthalene-2-carboxylic acid, having a good flavor, useful for foods, beverages and drugs |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | CA2508824C Alpha crystalline form of strontium ranelate, its preparation process, and the pharmaceutical compositions that contain it |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009035265A2 Calcium phosphate microspheres drug delivery system and process for preparing the same |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009033715A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008146018A3 Drug delivery system comprising matrix metalloproteinase inhibitors |
| 03/19/2009 | US20090076624 Synthetic osteochondral composite and method of fabrication thereof |
| 03/19/2009 | US20090076144 Deuterium-enriched bazedoxifene |
| 03/19/2009 | US20090076140 Pharmaceutical compositions containing sulphonic acid derivatives |
| 03/19/2009 | US20090076098 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones |
| 03/19/2009 | US20090076087 Deuterium-enriched etoricoxib |
| 03/19/2009 | US20090076070 Hetero compound |
| 03/19/2009 | US20090076065 Deuterium-enriched mk-0812 |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075987 Alkylacetylene substituted acyltryptophanols |